Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.460
+0.010 (0.22%)
At close: Jun 26, 2026, 4:00 PM EDT
4.540
+0.080 (1.79%)
After-hours: Jun 26, 2026, 4:49 PM EDT
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Treace Medical Concepts stock have an average target of 3.56, with a low estimate of 2.00 and a high estimate of 7.00. The average target predicts a decrease of -20.18% from the current stock price of 4.46.
Analyst Consensus: Hold
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Treace Medical Concepts stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $7 | Buy | Reiterates | $7 | +56.95% | May 11, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates $2 | Hold | Reiterates | $2 | -55.16% | May 11, 2026 |
| UBS | UBS | Hold Maintains $2.5 → $2.25 | Hold | Maintains | $2.5 → $2.25 | -49.55% | Mar 2, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $3 | Hold | Maintains | $3 | -32.74% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
206.26M
from 212.69M
Decreased by -3.02%
Revenue Next Year
221.81M
from 206.26M
Increased by 7.54%
EPS This Year
-0.91
from -0.80
EPS Next Year
-0.90
from -0.91
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 207.0M | 232.0M | |
| Avg | 206.3M | 221.8M | |
| Low | 204.2M | 215.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.7% | 12.5% | |
| Avg | -3.0% | 7.5% | |
| Low | -4.0% | 4.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.91 | -0.90 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.